ESC 365 - Optimising patient outcomes in non-valvular atrial fibrillation (NVAF): Peri-procedural use of non-vitamin K antagonist oral anticoagulants (NOACs) in cardiac interventions.

Open Access

Optimising patient outcomes in non-valvular atrial fibrillation (NVAF): Peri-procedural use of non-vitamin K antagonist oral anticoagulants (NOACs) in cardiac interventions.

Session: Optimising patient outcomes in non-valvular atrial fibrillation (NVAF): Peri-procedural use of non-vitamin K antagonist oral anticoagulants (NOACs) in cardiac interventions

Topic: Valvular Heart Disease

Speaker: Professor A. Banning (Oxford, GB) Doctor B. Gonska (Bad Nauheim, DE)

Sponsored by Bristol Myers Squibb and Pfizer

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speakers

Professor Adrian Paul Banning

John Radcliffe Hospital, Oxford (United Kingdom of Great Britain & Northern Ireland)

7 presentations

0 follower

Doctor Birgid Gonska

Kerckhoff Heart and Thorax Center, Bad Nauheim (Germany)

2 presentations

0 follower

Access the full session

Optimising patient outcomes in non-valvular atrial fibrillation (NVAF): Peri-procedural use of non-vitamin K antagonist oral anticoagulants (NOACs) in cardiac interventions

Speakers: Professor A. Banning, Doctor B. Gonska

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources